Hill-Rom's purchase of Welch Allyn Authorized by US Anti-Trust Regulators

Tuesday, July 14, 2015

Source: Mass Device

Hill-Rom Holdings (NYSE:HRC) said today that U.S. anti-trust regulators approved its pending, $2.05 billion acquisition of Welch Allyn and its portfolio of point-of-care diagnostic devices.

View All News »